Aurion Biotech, a biotechnology company in the clinical stage, is dedicated to developing a groundbreaking platform of advanced therapies aimed at curing blindness. Our primary focus lies in addressing corneal endothelial disease, for which we have developed one of the pioneering cell therapies that has undergone successful clinical validation. Our mission is to revolutionize corneal care through transformative treatments.
$120M • 2022 •
Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness.
Winning pitch decks that have closed millions in investments for leading startups and billion-dollar unicorns.
Investors see 5,000 pitch decks per year. Will you stand out?
No spam. Up to 2 emails/mo – only the good stuff!